FDA Panel Backs Testing Of Concurrent And Sequential Mammography CAD
This article was originally published in The Gray Sheet
Executive Summary
FDA should require sponsors of computer-aided detection for mammography to test their devices with both sequential and concurrent reading approaches, FDA's Radiological Devices Advisory Panel recommends
You may also be interested in...
No Clinical Data Needed For Some Computer-Aided Detection Devices - Panel
Clinical performance studies may not be necessary for all new or modified computer-aided detection tools used in radiology applications, an FDA advisory panel concluded Nov. 18
No Clinical Data Needed For Some Computer-Aided Detection Devices - Panel
Clinical performance studies may not be necessary for all new or modified computer-aided detection tools used in radiology applications, an FDA advisory panel concluded Nov. 18
CAD Mammography Leads To Unnecessary Patient Recalls, Biopsies – ECRI
An ECRI Institute evidence report released Dec. 15 on computer-aided detection mammography finds that while the technology does correctly diagnose breast cancer in some cases, its use led to patient callbacks in which the vast majority of women were actually healthy